Actively Recruiting
DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study
Led by Queen Mary Hospital, Hong Kong · Updated on 2025-07-24
50
Participants Needed
1
Research Sites
135 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To study the correlation between novel DIC markers and thrombin generation parameters with thrombotic and hemorrhagic complications of patients on ECMO support.
CONDITIONS
Official Title
DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 218 years or older
- Admitted to the mixed medical-surgical intensive care units of Queen Mary Hospital or Tuen Mun Hospital in Hong Kong
- Require veno-arterial (VA) or veno-venous (VV) extracorporeal membrane oxygenation (ECMO) support
You will not qualify if you...
- Patients who are on central VA-ECMO support
- Patients with missing clinical data
- Patients with pre-existing thromboembolism requiring long term anticoagulation prior to ECMO cannulation
- Post-operative admissions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Queen Mary Hospital
Hong Kong, Hong Kong
Actively Recruiting
Research Team
W
Wincy Ng
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here